08/12/2026
AI in pharma has reached an interesting moment.
The conversation is no longer about whether Artificial Intelligence COULD transform drug development. It is about something far more important: what has it actually changed?
Where is the evidence? What is working in discovery, clinical trials, and safety today? What remains more promise than proof? And perhaps most importantly, how are regulators responding as the technology moves faster than the frameworks built around it?
These are questions we have been eager to explore through AAPS Pharma.
In ‘Proof, Not Promise: How AI Is Actually Changing Pharma’, we are bringing them together in an evidence-based session examining the real impact of Big Data and AI across pharma, the evolving FDA, EMA, and ICH regulatory landscape, and what professionals should be watching over the next 12 to 18 months.
There is an extraordinary amount of noise around AI right now. We are excited to create space for a different kind of conversation: one grounded in evidence, regulation, and what is actually happening in the industry.
Visit aapspharma.com/events to learn more
08/06/2026
08/06/2026
07/24/2026
07/23/2026